Qube Research & Technologies LTD Arvinas, Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Arvinas, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 226,372 shares of ARVN stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
226,372
Previous 76,198
197.08%
Holding current value
$1.72 Million
Previous $1.46 Million
8.84%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ARVN
# of Institutions
249Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$63.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$47.4 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$29.4 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$29 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$25.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $403M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...